Publikationen

2026
2010
Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer

Weiss J, Sos M L, Seidel D, Peifer M, Zander T, Heuckmann J M, Ullrich R T, Menon R, Maier S, Soltermann A, Moch H, Wagener P, Fischer F, Heynck S, Koker M, Schottle J, Leenders F, Gabler F, Dabow I, Querings S, Heukamp L C, Balke-Want H, Ansen S, Rauh D, Baessmann I, Altmuller J, Wainer Z, Conron M, Wright G, Russell P, Solomon B, Brambilla E, Brambilla C, Lorimier P, Sollberg S, Brustugun O T, Engel-Riedel W, Ludwig C, Petersen I, Sanger J, Clement J, Groen H, Timens W, Sietsma H, Thunnissen E, Smit E, Heideman D, Cappuzzo F, Ligorio C, Damiani S, Hallek M, Beroukhim R, Pao W, Klebl B, Baumann M, Buettner R, Ernestus K, Stoelben E, Wolf J, Nurnberg P, Perner S, Thomas R K. Sci Transl Med. 2010; 2 (62): 62ra93. doi: 10.1126/scitranslmed.3001451

A flexible multiwell format for immunofluorescence screening microscopy of small-molecule inhibitors

Scholz A K, Klebl B M, Morkel M, Lehrach H, Dahl A, Lange B M. Assay Drug Dev Technol. 2010; 8 (5): 571-580. doi: 10.1089/adt.2009.0260

Small-molecule inhibition of APT1 affects Ras localization and signaling

Dekker F J, Rocks O, Vartak N, Menninger S, Hedberg C, Balamurugan R, Wetzel S, Renner S, Gerauer M, Scholermann B, Rusch M, Kramer J W, Rauh D, Coates G W, Brunsveld L, Bastiaens P I, Waldmann H. Nat Chem Biol. 2010; 6 (6): 449-456. doi: 10.1038/nchembio.362